Nasus Pharma Ltd. NSRX
AMEX · United States · Health Technology
$3.87+0.18 (+4.88%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-17 | -0.54 | -0.23 | -134.8% | +0.8%$3.62→$3.65 |
| 2026-08-17 | 2026-08-17 | -0.54 | — | — | +0.8%$3.62→$3.65 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.